Free shipping over €250 · Tracked, discreet delivery in Europe

Defensin mimetic

Brilacidin

In clinical trialsNot yet reviewedSmall molecule

In short: A synthetic small molecule modelled on host defence peptides. Studied in trials for oral mucositis and infection.

Regulatory status

  1. Cosmetic ingredient
  2. Research compound
  3. In clinical trials
  4. Approved medicine

In human clinical trials and not yet approved by the FDA or the EMA. Results to date are from trial populations under medical supervision.

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Common questions

Is Brilacidin an approved medicine?

In clinical trials. In human clinical trials and not yet approved by the FDA or the EMA. Results to date are from trial populations under medical supervision.

How much human research is there on Brilacidin?

A full research summary for this compound has not been published in the library yet. The status and class above are current.

Does UU supply Brilacidin?

No. It appears in the library for reference only, so the field can be read in one place.

More in Immune & airways

Back to the library
  • Researchuu

    KPV

    Alpha-MSH fragment

    Preclinical
  • Researchuu

    Thymosin alpha-1

    Thymic peptide

    Human trials
  • Researchuu

    Thymalin

    Thymic peptide preparation

    Early human data
  • Researchuu

    LL-37

    Antimicrobial peptide

    Early human data
  • Researchuu

    VIP

    Neuropeptide

    Human trials
  • Researchuu

    ARA-290

    Erythropoietin-derived peptide

    Early human data

The UU library is an educational reference. It is not medical advice, does not make a health claim, and does not tell anyone how to use a compound. UU products are sold for laboratory research use only and are not for human consumption. Regulatory status changes: confirm it with the relevant authority before relying on it.